Piper Sandler Issues Positive Forecast for Trupanion (NASDAQ:TRUP) Stock Price

Trupanion (NASDAQ:TRUP) had its price target increased by Piper Sandler from $45.00 to $57.00 in a report released on Thursday, Benzinga reports. They currently have a neutral rating on the financial services provider’s stock.

Several other equities research analysts have also issued reports on the company. Northland Securities lifted their price target on Trupanion from $35.00 to $45.00 and gave the stock a “market perform” rating in a research note on Thursday, September 19th. Stifel Nicolaus raised their target price on Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a research note on Monday, September 23rd. Evercore ISI raised shares of Trupanion to a “strong-buy” rating in a research report on Friday, August 9th. Bank of America raised their target price on shares of Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a research report on Friday, September 20th. Finally, William Blair initiated coverage on shares of Trupanion in a research note on Friday, July 19th. They set an “outperform” rating on the stock. Four analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Trupanion presently has a consensus rating of “Moderate Buy” and a consensus target price of $44.67.

Trupanion Price Performance

NASDAQ TRUP traded up $0.80 on Thursday, hitting $55.58. The stock had a trading volume of 177,032 shares, compared to its average volume of 678,395. The firm has a 50-day moving average of $46.92 and a 200-day moving average of $36.00. The company has a market capitalization of $2.34 billion, a price-to-earnings ratio of -171.19 and a beta of 1.73. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.63 and a current ratio of 1.63. Trupanion has a 52-week low of $19.69 and a 52-week high of $57.90.

Trupanion (NASDAQ:TRUP) last posted its earnings results on Wednesday, October 30th. The financial services provider reported $0.03 EPS for the quarter, topping the consensus estimate of ($0.06) by $0.09. Trupanion had a negative return on equity of 4.42% and a negative net margin of 1.08%. The business had revenue of $327.50 million during the quarter, compared to analysts’ expectations of $321.79 million. During the same period in the previous year, the business earned ($0.10) earnings per share. The firm’s revenue was up 14.6% on a year-over-year basis. Equities analysts expect that Trupanion will post -0.34 EPS for the current year.

Insider Buying and Selling at Trupanion

In related news, CEO Margaret Tooth sold 7,500 shares of the company’s stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total value of $348,600.00. Following the transaction, the chief executive officer now owns 99,984 shares in the company, valued at $4,647,256.32. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, CEO Margaret Tooth sold 7,500 shares of the stock in a transaction that occurred on Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total transaction of $348,600.00. Following the sale, the chief executive officer now owns 99,984 shares in the company, valued at $4,647,256.32. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Fawwad Qureshi sold 624 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $46.54, for a total transaction of $29,040.96. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 8,764 shares of company stock worth $405,238. 5.50% of the stock is owned by insiders.

Hedge Funds Weigh In On Trupanion

A number of hedge funds have recently bought and sold shares of the business. ProShare Advisors LLC boosted its holdings in Trupanion by 33.8% in the first quarter. ProShare Advisors LLC now owns 121,417 shares of the financial services provider’s stock worth $3,352,000 after purchasing an additional 30,645 shares during the last quarter. Susquehanna Fundamental Investments LLC purchased a new position in shares of Trupanion in the 1st quarter worth $473,000. Renaissance Technologies LLC bought a new stake in shares of Trupanion in the second quarter worth $4,739,000. Marshall Wace LLP increased its position in Trupanion by 11.9% during the second quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock valued at $32,181,000 after acquiring an additional 116,496 shares during the last quarter. Finally, Connors Investor Services Inc. boosted its position in Trupanion by 31.3% in the second quarter. Connors Investor Services Inc. now owns 113,567 shares of the financial services provider’s stock worth $3,339,000 after purchasing an additional 27,042 shares during the last quarter.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.